Moneycontrol PRO

business

Inhaler launch in EU to add $55mn to Cipla FY15 rev: Nomura

Saion Mukherjee, Head Of Research, Nomura says this is a positive development for the company. Nomura has raised its target price to Rs 569. He expects the product to add USD 27 million to Cipla revenue in FY15 and USD 110 million in FY16.

first published: Sep 2, 2014 11:51 am

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347